Treatment options
Immunotherapy for cancer: when should it be discussed and what information matters?
Questions about immunotherapy need to be considered alongside the cancer type, biomarkers, previous treatment, current status, and treatment goals.
This may be relevant if
- You want to understand whether immunotherapy may be relevant to a particular case.
- PD-L1, MSI/MMR, or another result needs to be considered in context.
- The disease has returned or progressed after earlier treatment.
What information matters?
Start with what you have. Missing information can be marked and completed later.
- Cancer type, stage, and disease sites
- Biomarkers already tested
- Treatment history and important side effects
- Latest imaging or pathology
A practical next step
- 1Organise the basic information in the Cancer Passport.
- 2Record results that are missing or uncertain.
- 3Request a review to discuss options and treatment sequence.
Not a diagnosis and not final medical advice. Must be reviewed by a doctor.
Review immunotherapy options
A navigator helps organise the case context before questions go to a doctor or provider.
After submission, a human navigator reviews your request and contacts you through your chosen channel. The WhatsApp message already includes this page context, so you do not need to explain from the beginning.
Clinical data is not requested in the form and is not sent to analytics. Do not send medical reports through WhatsApp or email; use the secure upload page. We do not promise eligibility or any treatment outcome.
Use a case summary, not a copied medical history
The Cancer Passport keeps the information you choose to save in one place so a later review can start from the same context.
Ready to take the next step?
Start with the information you have. A navigator can help identify what to review next.
Prepare for your next consultation
Use the free six-question tool to prepare questions for your doctor.